HLA-G and diabetic kidney disease: Furthermore, urinary α1-microglobulin (α1-MG) and β2-microglobulin (β2-MG) are established biomarkers for renal tubulointerstitial injury, indicating their utility in monitoring the progression of DKD (22–24).